Rezultati
eNauka >
Results >
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases
| Title: | Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases | Authors  : | Gerhardt, Kristin; ...; Sretenović, Aleksandra M.; ...; Todorović, Milena R.   ; Bila, Jelena S. ; ...; Vučinić, Vladan |
Issue Date: | 2021 | Publication: | Frontiers in oncology | ISSN: | 2234-943X Frontiers in Oncology Search Idenfier |
Publisher: | [Lausanne : Frontiers Research Foundation] | Type: | Article | Collation: | vol. 11 str. 737645 | DOI: | 10.3389/fonc.2021.737645 | WoS-ID: | 000702032500001 | Scopus-ID: | 2-s2.0-85116194086 | PMID: | 34604075 | PMCID: | PMC8481921 | URI: | https://enauka.gov.rs/handle/123456789/825238 | URL: | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.737645/full | Project: | German Research Foundation (DFG) Universitat Leipzig within the program of Open Access Publishing |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21M21 |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.